1. CV
Firstname: NIAZ
Familyname(surname): ABDUALRAB
Dateof birth: 9th
April1975
Placeof birth: ADEN-YEM
Currentnationality: YEMENI
Email: niazabdo@yahoo.com
Tell +967777278548
Academic qualificationsand dates:
 Bachelor degreein medicine ( 2002-Cario University Facultyof Medicine Egypt)
 Internationaldiplomacourse on malaria program planning&management organized by
Tehran university of medical sciences .world health organization &Nationalinstate of health
research (15april-16 June2011)
Postgraduatetraining:
 Regional Training Courseon malaria CaseManagement organized byBlue Nile National
Institute for CommunicableDisease Gezira University .Sudan in collaboration with The
World Health Organization/Eastern Mediterranean RegionalOffice (WHO/EMRO)(22-29
November20142011).
 World HealthOrganization RegionalWorkshopFor Training of consultants on methodsof
antimalarialtherapeutic efficacy testing (TET) &malaria microscopy conducted in Blue Nile
National Institute for CommunicableDisease Gezira University .Sudan (12-28 July2011)
 Refresh courseon assessing therapeutic efficacytestof antimalariadrugs using WHO
protocol (August2009)

 Training courseon Epidemiology in action ( EIA)"organized byLiverpoolschoolfor tropical
medicine ( 3 monthscourse) (26 April – 22 July2008)
 Quality control andQualityassuranceof malaria diagnosis , organized by Liverpoolschoolfor
tropicalmedicine ( 2 monthscourses )( December2005 – January 2006)
OtherCourses:

2.  2007: T.B. Diagnosisand treatment organized by National T.B.controlprogram.
 2006: Statementof health problem and solution methods organized by Dutch program for
primaryhealth careSupport.
 2004: Malaria prevention and control organized by NMCP.
Researcher Experience:
 Principalinvestigator for Efficacyand safetyof artesunate+sulfadoxine/pyrimethamineand
artemether-lumefantrinefor thetreatment of uncomplicated Plasmodium falciparum
malaria At Bajil , Tour Bani Qais, Shares, alqaflah , Jabal Ash Sharq, AlUdayn districts in
Yemen,(2012)
 Temporary( WHO) adviser for revising theclinical formsof AMD therapeutic efficacytest
studies in Pakistan(26-31march 2012)
 Temporary( WHO) adviserforrevising theclinicalformsof AMD therapeutic efficacy test
studies in Somalia24 December 2011 –6 January2012
 Coordinatorand investigator of studieson therapeutic efficacy of antimalarialdrugs(1st
and
2nd
line artesunate+sulfadoxine/pyrimethamineand artemether-lumefantrine respectively).
In this capacity my responsibilities included over all coordination of the study in 6 sentinel
sites, monitoring and quality control(adherenceto study protocol, CRF, validation of the
malaria microscopyetc)(2009-2010).
 Co investigator on studiesof therapeutic efficacyof anti malaria drugs(chloroquineand
artesunate+sulfadoxine/pyrimethamine in treatmentof uncomplicated malaria( 2007).
Postsheld(typeof post,institution/authority, dateschronologicallystarting with current
appointment):
 At present: Directorof Malaria CaseManagementUnit in NMCP, Yemen.
 2006- 2009: Technicalmanger in MADINAT -ALSHRK ruralhospital, Yemen.

3. Selected relevantpublications:
(High efficacy of two Artmisinin-based combinations: Artesunate+ sulfadoxinepyrimethamine
and artemether-lumefantrinefor falciparum malaria in Yemen)
Article in Malaria Journal· December 2015
ImpactFactor: 3.11 · DOI: 10.1186/s12936-015-0970-2
See discussions, stats, and author profilesfor this publication at:
https://www.researchgate.net/publication/283790259